PT  - JOURNAL ARTICLE
ED  - , 
TI  - Deletion of LATS1/2 Hippo Pathway Kinases Enhances Antitumor Immunity
AID  - 10.1158/2159-8290.CD-RW2016-236
DP  - 2017 Feb 01
TA  - Cancer Discovery
PG  - OF8--OF8
VI  - 7
IP  - 2
4099  - http://cancerdiscovery.aacrjournals.org/content/7/2/OF8.short
4100  - http://cancerdiscovery.aacrjournals.org/content/7/2/OF8.full
SO  - Cancer Discov2017 Feb 01; 7
AB  - LATS1/2 loss enhances tumor immunogenicity to promote antitumor immune responses and tumor regression.